Triflumidate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H14F3NO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V6G94Z48FK, chemically known as carbanilic acid, m-benzoyl-n-((trifluoromethyl)sulfonyl)-, ethyl ester but generally known as triflumidate, which bears US NIH Compound Identifier 32259. European Medicines Agency schedules Triflumidate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11286MIG. The term TRIFLUMIDATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). TRIFLUMIDATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule triflumidate under HS 29350090 and SITC 51580. As of Q4 2014, TRIFLUMIDATE remains the US FDA Preferred Term for this commodity. Triflumidate bears US NLM identifiers UMLS ID C0601852 and NCI Concept Code C66634. SMILES: S(=O)(=O)(N(C1CC(CCC1)C(=O)C1CCCCC1)C(=O)OCC)C(F)(F)F.